A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2001
11/29/2001	CA2410014A1 Medicaments for treating colics
11/29/2001	CA2409873A1 Hcv variants
11/29/2001	CA2409868A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	CA2409768A1 Cyclic amino acid derivatives useful as pharmaceutical agents
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408562A1 Dehydroascorbic acid formulations and uses thereof
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2408036A1 Combination of growth hormone secretagogues and antidepressants
11/29/2001	CA2407964A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2407028A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001	EP1158046A1 Superoxide Dismutase-4
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1158000A1 Crystal structure data of cystalysin and use thereof for the design and preparation of inhibitor molecules
11/28/2001	EP1157696A2 Treatment of rumen acidosis with alpha-amylase inhibitors
11/28/2001	EP1157042A1 Production of tetravalent antibodies
11/28/2001	EP1157033A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
11/28/2001	EP1157024A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157017A1 N-substituted imide derivatives with serotonergic activity
11/28/2001	EP1157000A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/28/2001	EP1156853A2 Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or h 2? receptor antagonists
11/28/2001	EP1156852A2 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h 2? receptor antagonists
11/28/2001	EP1156806A1 Pharmaceutical composition containing proton pump inhibitors
11/28/2001	EP1156771A2 Interferon tau mutants and methods for making them
11/28/2001	EP0991407B1 Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations
11/28/2001	EP0804469B1 T-cell affecting peptides
11/28/2001	EP0783503B1 2,7-substituted octahydro-1h-pyrido[ 1,2-a]pyrazine derivatives
11/28/2001	EP0695303B1 Pyridinium salts and their use for controlling helicobacter bacteria
11/28/2001	EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/28/2001	CN1324364A Phosphoglycolipid and methods for its use
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324349A Pyrazine compounds
11/28/2001	CN1324236A Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use
11/28/2001	CN1324232A Expandable gastroretentive therapeutic system with prolonged stomach retention time
11/28/2001	CN1323632A Shenbikang capsule, tablet, bolus and oral liquid for treating kidney disease and their prepn.
11/28/2001	CN1323628A Kidney-invigorating and male sexual function improving traditional Chinese medicine prepn.
11/28/2001	CN1323620A Gastrosis treating medicine
11/28/2001	CN1323612A Mihaigao ointment made of honey, sepium and other traditional Chinese medicine and its prepn.
11/28/2001	CN1323609A Weitai capsule for treating stomach disease
11/28/2001	CN1323605A Antibiotics obtaining method via plant immunity
11/28/2001	CN1323604A Foamed disease-treating ointment
11/28/2001	CN1323603A Cold-preventing and spleen-invigorating paste
11/28/2001	CN1323599A Medicine for treating diseases of digestive system
11/28/2001	CN1323598A Antifatigue capsule
11/28/2001	CN1323597A External-use antidiarrbeic and its prepn.
11/28/2001	CN1075382C Medicinal ice for oral cavity and preparing process thereof
11/28/2001	CN1075377C Composite mannosans peptides oral liquor
11/27/2001	US6323234 Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity
11/27/2001	US6323230 Epicuaneous route in the case of dermatological illnesses like psoriasis, atopic dermatitis and other similar affections, or when administered by oral or rectal route in the case of diseases of the epithelia of the lower intestines
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323216 Selective antagonists of the 5-ht.sub.3 serotonin-like receptor and can therefore be used, as anti-emetics as well as in various pathological conditions of the central nervous system, and as antitussives.
11/27/2001	US6323214 Allosteric adenosine receptor modulators
11/27/2001	US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative
11/27/2001	US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders.
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	US6323204 Analgesics, antiinflammatory agents and antiischemic agents
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323180 Protease inhibitors; inhibit replication of hepatitis c virus
11/27/2001	US6322825 Compositions containing thymol and carvacrol and methods of treating gastrointestinal infections with the compositions
11/27/2001	US6322806 Over-coated chewing gum formulations including tableted center
11/27/2001	CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals
11/25/2001	CA2309518A1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/25/2001	CA2309417A1 Apoptotic entities for use in treatment of endothelium dysfunction disorders
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001087979A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087977A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087938A2 Polynucleotide sequence encoding a putative cell adhesion molecule
11/22/2001	WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	WO2001087890A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
11/22/2001	WO2001087889A1 Crf receptor antagonists and methods relating thereto
11/22/2001	WO2001087886A1 Crf receptor antagonists and methods relating thereto
11/22/2001	WO2001087881A1 Piperidyindoles as serotonin receptor ligands
11/22/2001	WO2001087874A1 Process for producing crystal
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087844A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087840A1 Propanoic acid derivatives as integrin receptor antagonists
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087831A2 Novel amorphous form of omeprazole salts
11/22/2001	WO2001087830A2 Substituted thioacetamides
11/22/2001	WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
11/22/2001	WO2001087343A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087328A2 Interleukin-1 inhibitors in the treatment of diseases
11/22/2001	WO2001087305A2 Method for treating functional dyspepsia using alosetron

1 ... 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 ... 1258